Cantalupo G, Alifano P, Roberti V, Bruni C B, Bucci C
Dipartimento di Biologia e Patologia Cellulare e Molecolare L.Califano and Centro di Endocrinologia ed Oncologia Sperimentale G.Salvatore del Consiglio Nazionale delle Ricerche, Università degli Studi di Napoli Federico II, Italy.
EMBO J. 2001 Feb 15;20(4):683-93. doi: 10.1093/emboj/20.4.683.
Rab7 is a small GTPase that controls transport to endocytic degradative compartments. Here we report the identification of a novel 45 kDa protein that specifically binds Rab7GTP at its C-terminus. This protein contains a domain comprising two coiled-coil regions typical of myosin-like proteins and is found mainly in the cytosol. We named it RILP (Rab-interacting lysosomal protein) since it can be recruited efficiently on late endosomal and lysosomal membranes by Rab7GTP. RILP-C33 (a truncated form of the protein lacking the N-terminal half) strongly inhibits epidermal growth factor and low-density lipoprotein degradation, and causes dispersion of lysosomes similarly to Rab7 dominant-negative mutants. More importantly, expression of RILP reverses/prevents the effects of Rab7 dominant-negative mutants. All these data are consistent with a model in which RILP represents a downstream effector for Rab7 and both proteins act together in the regulation of late endocytic traffic.
Rab7是一种小GTP酶,可控制向内吞降解区室的转运。在此,我们报告鉴定出一种新的45 kDa蛋白,该蛋白在其C末端特异性结合Rab7GTP。这种蛋白包含一个结构域,该结构域由两个典型的肌球蛋白样蛋白的卷曲螺旋区域组成,主要存在于胞质溶胶中。我们将其命名为RILP(Rab相互作用溶酶体蛋白),因为它可以被Rab7GTP有效地募集到晚期内体和溶酶体膜上。RILP-C33(该蛋白缺少N端一半的截短形式)强烈抑制表皮生长因子和低密度脂蛋白的降解,并与Rab7显性负性突变体类似地导致溶酶体分散。更重要的是,RILP的表达可逆转/预防Rab7显性负性突变体的作用。所有这些数据都与一个模型一致,即RILP代表Rab7的下游效应器,并且这两种蛋白共同作用于晚期内吞运输的调节。